Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials

Find Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Near You

Analysing cEllular Bioenergetics aNd Structural aDaptations in the qUadriceps Muscle befoRe and After endobroNChial Valve treatmEnt

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

Objective: To investigate the physiological and structural adaptations of peripheral muscle function at a cellular level in response to EBV treatment. Study design: A single center, prospective clinical trial with a single-arm pretest-posttest design. Patients with severe emphysema who will receive a bronchoscopic lung volume reduction treatment are asked to undergo additional in-magnet exercise testing and muscle biopsies before and after placement of EBVs. Study population: Patients with severe emphysema who are scheduled to undergo EBV treatment. Main study parameters/endpoints: The difference in quadriceps phosphocreatine concentration (PCr), quadriceps inorganic phosphorus concentration (Pi), and quadriceps pH at rest, during progressive exercise, and recovery rate will be measured by 31P-MRS to assess the physiological effect of EBV treatment on skeletal muscle function and its bioenergetics. Furthermore, we will perform a detailed histological and biochemical analysis of muscle fiber type composition, mitochondrial density, master regulators of muscle oxidative programming, and mitochondrial respiration before and after EBV treatment.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Patient is scheduled for a bronchoscopic lung volume treatment using one-way endobronchial valves;

• Patient read, understood and signed the Informed Consent Form.

Locations
Other Locations
Netherlands
Univeristy Medical Center Groningen
RECRUITING
Groningen
Contact Information
Primary
Else ter Haar, MD
e.a.m.d.ter.haar@umcg.nl
+31503619194
Backup
Jorine Hartman, PhD
j.hartman@umcg.nl
+31503619194
Time Frame
Start Date: 2024-10-01
Estimated Completion Date: 2025-12-01
Participants
Target number of participants: 15
Treatments
EBV-patients
Patients who are scheduled for a bronchoscopic lung volume reduction treatment using endobronchial valves.
Sponsors
Leads: University Medical Center Groningen

This content was sourced from clinicaltrials.gov